Upstream Bio plans to IPO to advance its Phase 2 drug candidate, verekitug, for severe asthma and chronic rhinosinusitis.

The fall flurry of biotech IPOs shows no signs of abating, with Upstream Bio becoming the latest company to express an ...

Who is Venrock Management VI, LLC? Venrock Management VI, LLC has an estimated net worth of $172 Million. This is based on reported shares across multiple companies, which include CASTLIGHT HEALTH ...

Venrock Healthcare Capital Partners, Fairmount, TCGX, and venBio Partners all co-led the financing. Candid was created by Ken Song earlier this year, after his last company, RayzeBio ...

According to Altruist, the click-to-trade feature is powered by Moment, allows users to quickly create orders, and offers ...

Pakman is a partner at VC firm Venrock where he invests in early-stage startups. He was an early investor and board member of Dollar Shave, which was bought by Unilever for $1 billion this summer.

According to a press statement, the Oruka PIPE deal included participation from new and existing investors including Braidwell LP, Venrock Healthcare Capital Partners, Fairmount, Access ...

When Venrock makes an investment, people tend to notice. That’s no surprise, given that the VC firm has proved it has an unusually accurate finger on the pulse of the health care industries of ...

(Abridge also just rolled out across Kaiser Permanente.) Others in the space include Cathay Innovation-backed Nabla and ...

I’m not sure, but I think most people agree history repeats itself. Now, if you disagree, I’d love to hear, because I’m not sure I’ve ever heard a full-throated rejoinder to this idea.

Who is Venrock Partners Management VI, LLC? Venrock Partners Management VI, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares ...